Fingerprint
Dive into the research topics of 'Phase II trial of high-dose interleukin-2 and lymphokine-activated killer cells in hodgkin’s disease and non-hodgkin’s lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II trial of high-dose interleukin-2 and lymphokine-activated killer cells in hodgkin’s disease and non-hodgkin’s lymphoma
Kim A. Margolin, Frederick R. Aronson, Mario Sznol, Michael B. Atkins, Nicolae Ciobanu, Richard I. Fisher, Geoffrey R. Weiss, James H. Doroshow, Michael H. Bar, Michael J. Hawkins, James W. Mier, Elisabeth Paietta, Ellen P. Gaynor, David H. Boldt
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations